Shares of genomics company Illumina (NASDAQ ... would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock dropped 6.3% on ...

Shares of genomics company Illumina (NASDAQ ... would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock dropped 8.6% on ...

Caprock Group LLC raised its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 3.7% in the 4th quarter, according to the ...

Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday. The company posted quarterly ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Shares of genomics company Illumina (NASDAQ ... but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock ...

A number of other institutional investors and hedge funds have also made changes to ... weighed in on the stock. Morgan Stanley cut their price objective on shares of Illumina from $156.00 to ...

Shares of genomics company Illumina (NASDAQ ... but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock ...

This reflects how the analysts covering the stock have collectively ... to an estimated 'Revenue- Core Illumina' of $1.07 billion. The estimate points to a change of -2.5% from the year-ago ...

Investors should keep in mind that an aggregate change may not ... On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination indicates that Illumina will most likely ...